These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 144262)

  • 1. Tumor-specific immunity in sarcoma patients.
    Rella W; Kotz R; Arbes H; Leber H
    Oncology; 1977; 34(5):219-23. PubMed ID: 144262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immune-status in patients with bone and soft-tissue sarcomas.
    Kotz R; Rella W; Salzer M
    Recent Results Cancer Res; 1976; (54):197-205. PubMed ID: 1070721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic reactions in patients with soft tissue sarcomas after surgical treatment].
    Malysheva SF; Romanova OA; Slivinskaia ZP
    Vopr Onkol; 1978; 24(11):30-5. PubMed ID: 741697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human tumor-associated antigens detected by serological techniques: analysis of autologous humoral immune responses to primary and metastatic human sarcomas by an enzyme-linked immunoabsorbent solid-phase assay (ELISA).
    Roth JA; Wesley RA
    Cancer Res; 1982 Oct; 42(10):3978-86. PubMed ID: 6955005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of sarcomas.
    Mitchell MS
    Clin Orthop Relat Res; 1980; (153):26-30. PubMed ID: 6160937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
    Cohen AM; Ketcham AS; Morton DL
    J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immune reactions in assessing the disease prognosis in soft tissue sarcomas].
    Klimenkov AA; Kadagidze ZG; Gladikov IuV
    Vopr Onkol; 1979; 25(1):3-8. PubMed ID: 425395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hypersensitivity reaction in patients with bone and soft tissue sarcoma.
    Shinohara N; Fukuma H; Nishio A
    Nihon Seikeigeka Gakkai Zasshi; 1979 Jun; 53(6):705-11. PubMed ID: 490017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Humoral immunity in human sarcomas].
    Sergeev SI; Bergol'ts VM; Kovalev BN; Timofeevskaia EA
    Vopr Onkol; 1976; 22(8):17-21. PubMed ID: 1069401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic aspects of human sarcomas.
    Pritchard DJ; Ivins JC; Ritis RE
    Recent Results Cancer Res; 1976; (54):185-96. PubMed ID: 796919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone sarcomas: etiology and immunology.
    Sinkovics JG; Thota H; Romero JJ; Waldinger R
    Can J Surg; 1977 Nov; 20(6):494-503. PubMed ID: 412577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.
    Vánky F; Klein E; Willems J; Böök K; Ivert T; Péterffy A; Nilsonne U; Kreicbergs A; Aparisi T
    Cancer Immunol Immunother; 1986; 21(1):69-76. PubMed ID: 3455878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological characteristics of sarcomas patients with clonogenic tumors.
    Avdonkina NA; Danilova AB; Nekhaeva TL; Prosekina EA; Emelyanova NV; Novik AV; Girdyuk DV; Gafton GI; Baldueva IA
    Immunobiology; 2021 Jul; 226(4):152094. PubMed ID: 34052775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity against soft-tissue sarcomas.
    Maki RG
    Curr Oncol Rep; 2003 Jul; 5(4):282-7. PubMed ID: 12781069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. I. Evaluation of 46 patients with sarcoma.
    Vánky F; Willems J; Kreicbergs A; Aparisi T; Andréen M; Broström LA; Nilsonne U; Klein E; Klein G
    Cancer Immunol Immunother; 1983; 16(1):11-6. PubMed ID: 6605799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas.
    Dancsok AR; Setsu N; Gao D; Blay JY; Thomas D; Maki RG; Nielsen TO; Demicco EG
    Mod Pathol; 2019 Dec; 32(12):1772-1785. PubMed ID: 31263176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymus-dependent and nonthymus-dependent lymphocytes in patients with sarcomas.
    Pritchard DJ; Miller GC; Ritts RE; Ivins JC
    Cancer; 1977 Aug; 40(2):803-7. PubMed ID: 302142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of cytotoxic reactivity to cultured normal skin fibroblasts in sera from normal and sarcoma-bearing patients.
    Catapano MS; Brown JM; Rosenberg SA
    Cancer Res; 1980 Apr; 40(4):979-83. PubMed ID: 6928402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.